Chronic disease management: Considerations for international adoption

Measuring rates of return for disease management programmes is controversial and challenging. There are significant costs associated with the disease management programme design, evaluation and maintenance. The literature shows that a disease management programme is not a guarantee of cost savings, but in addition to community health improvements and improved clinical outcomes, desired cost savings can be realised if the programme is designed correctly.